Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.55 USD | +0.71% | +4.10% | +28.64% |
04-09 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
04-08 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.64% | 4.77B | |
+25.83% | 661B | |
+26.83% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.87% | 231B | |
+5.31% | 200B | |
-8.79% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating